drugset / Trial / NCT00136773

Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus

NCT00136773

Phase 4 Completed 332 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

Type 2 diabetes mellitus is usually associated with high blood pressure, which is a risk factor for kidney disease. Aggressive blood pressure reduction is an important strategy to protect the kidney and reduce urinary protein which develops with kidney disease. This study will evaluate the effects of amlodipine/benazepril in reducing blood pressure and urinary protein in hypertensive subjects with type 2 diabetes mellitus.

Timeline

Start
2003-04
Primary completion
2005-10
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Benazepril Unknown

Indications